medigraphic.com
ISSN 1727-897X (Electronic)

2013, Number 4

<< Back Next >>

Medisur 2013; 11 (4)

Emergency Splenectomy in a patient with primary immune thrombocytopenia and hemoperitoneum

Dita SLM, Consuegra DJE, Jaime GC

Language: Spanish
References: 15
Page: 464-468
PDF size: 134.76 Kb.


ABSTRACT

Primary immune thrombocytopenia is an acquired autoimmune disease, with a very variable clinical course, which causes an accelerated destruction by antibodies and an impaired platelet production. A case of a 40 year-old female patient of rural origin with a history of mitral stenosis and atrial fibrillation, diagnosed two months prior to her admission to the Dr. Gustavo Aldereguía Lima University General Hospital in Cienfuegos, is presented. She attended the hospital with ecchymosis and petechiae on the lower and upper limbs. After confirming a severe thrombocytopenia (5x109/ l), she was admitted to the Hematology Department. Possible primary immune thrombocytopenia was found. During her stay in the hospital, her clinical condition was complicated by hemoperitoneum. The patient underwent surgery which confirmed the presence of four liters of blood in the abdominal cavity with few clots, bleeding and fissure in the left ovary and adherent clots. An early clamping of the splenic artery, evacuation of the hemoperitoneum, left adnexectomy, splenectomy and resection of accessory spleen were performed. The patient progressed satisfactorily.


REFERENCES

  1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009 ; 113 (11): 2386-93.

  2. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005 ; 106 (7): 2244-51.

  3. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009 ; 13 (26): 6511-21.

  4. Donato H, Cedola A, Elena G, Rapetti MC, Rossi N, Ramos A, et al. Púrpura trombocitopénica inmunitaria. Guía de diagnóstico y tratamiento. Arch Argent Pediatr [revista en Internet]. 2010 [ cited 23 Ene 2012 ] ; 108 (2): [aprox. 14p]. Available from: http://www.scielo.org.ar/scielo.php?pid=S0325-0 0752010000200021&script=sci_arttext.

  5. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 ; 115 (2): 168-86.

  6. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000 ; 160 (11): 1630-8.

  7. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001 ; 97 (9): 2549-54.

  8. Monteagudo E, Fernández-Delgado R, Sastre A, Toll T, Llort A, et al. Protocolo de estudio y tratamiento de la trombocitopenia inmune primaria (PTI-2010). An Pediatr(Barc). 2011 ; 74 (6): 414e1-414e8.

  9. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006 ; 432 (11): 2377-83.

  10. Sociedad Española de Hematología y Hemoterapia. Directrices de diagnóstico, tratamiento y seguimiento de la PTI: Documento de consenso [Internet]. Madrid: Produg Multimedia, S.L; 2011. [ cited 23 Ene 2012 ] Available from: http://www.sehh.es/documentos/40/Guia PTI.pdf.

  11. Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, et al. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica. 2005 ; 90 (1): 72-7.

  12. Spahr JE, Rodgers GM. Treatment of immune mediated thrombocytopenic purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients. Am J Hematol. 2008 ; 83 (2): 122-5.

  13. Boruchov DM, Gururangan S, Driscoll MC, Bussel JB. Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP). Blood. 2007 ; 110 (10): 3526-31.

  14. Neunert C, Lim W, Crowther M, Cohen A, Solberg L, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011 ; 117 (6): 4190-207.

  15. Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L, et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet. 2009 ; 373 (9674): 641-8.




2020     |     www.medigraphic.com